Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Solid Biosciences Inc. SLDB

Full chart Compare
Set alert

Price alert · SLDB

All alert types
6.52 USD +0.24 (+3.82%)

At closeNov 4, 2026, 7:00 PM EST

6.60 +0.08 +1.23%

After hours · Nov 4, 7:00 PM ET

6.23 Day range 6.68
3.79 52-week range 11.45
YTD
+15.60%
1 year
+47.85%

Financial health

Altman Z-Score

3.92 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 3

Valuation

P/E -2.8×
FY 2016: -20.2×FY 2017: -14.0×FY 2018: -11.9×FY 2019: -1.6×FY 2020: -4.5×FY 2021: -2.6×FY 2022: -0.5×FY 2023: -1.3×FY 2024: -1.3×FY 2025: -2.8×
FY 2016 5y median -1.3× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 13.7×FY 2022: 5.7×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 2.7×
FY 2016: -5.2×FY 2017: -12.3×FY 2018: 7.1×FY 2019: 2.2×FY 2020: 3.0×FY 2021: 0.9×FY 2022: 0.2×FY 2023: 1.0×FY 2024: 1.2×FY 2025: 2.7×
FY 2016 5y median 1.0× FY 2025
P/FCF -3.1×
FY 2016: -21.2×FY 2017: -16.0×FY 2018: -11.4×FY 2019: -1.8×FY 2020: -6.8×FY 2021: -2.4×FY 2022: -0.5×FY 2023: -1.3×FY 2024: -1.6×FY 2025: -3.1×
FY 2016 5y median -1.6× FY 2025
EV/EBITDA -2.6×
FY 2016: -16.7×FY 2017: -12.4×FY 2018: -10.7×FY 2019: -0.9×FY 2020: -2.9×FY 2021: -1.0×FY 2022: 0.8×FY 2023: -0.8×FY 2024: -0.9×FY 2025: -2.6×
FY 2016 5y median -0.9× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 5.1×FY 2022: -10.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -31.9%
FY 2016: -4.7%FY 2017: -6.2%FY 2018: -8.7%FY 2019: -54.2%FY 2020: -14.6%FY 2021: -42.3%FY 2022: -220.5%FY 2023: -78.4%FY 2024: -61.7%FY 2025: -31.9%
FY 2016 5y median -61.7% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -530.5%FY 2022: -1315.2%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -530.0%FY 2022: -1062.3%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -96.8%
FY 2016: 25.5%FY 2017: 88.0%FY 2018: -59.8%FY 2019: -146.4%FY 2020: -66.8%FY 2021: -34.7%FY 2022: -40.6%FY 2023: -75.9%FY 2024: -90.9%FY 2025: -96.8%
FY 2016 5y median -75.9% FY 2025
ROIC -89.1%
FY 2016: -75.8%FY 2017: -84.5%FY 2018: -59.5%FY 2019: -137.0%FY 2020: -58.1%FY 2021: -34.4%FY 2022: -44.3%FY 2023: -68.3%FY 2024: -80.4%FY 2025: -89.1%
FY 2016 5y median -68.3% FY 2025
ROA -75.0%
FY 2016: -53.0%FY 2017: -68.4%FY 2018: -53.6%FY 2019: -113.3%FY 2020: -51.6%FY 2021: -31.1%FY 2022: -33.0%FY 2023: -58.2%FY 2024: -66.1%FY 2025: -75.0%
FY 2016 5y median -58.2% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -40.6%FY 2023: -100.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -38.1%
FY 2016: -289.6%FY 2017: -114.5%FY 2018: -38.0%FY 2019: -57.6%FY 2020: 27.5%FY 2021: 16.4%FY 2022: -47.3%FY 2023: 2.0%FY 2024: -24.4%FY 2025: -38.1%
FY 2016 FY 2025
EPS (diluted) 35.0%
FY 2016: -238.0%FY 2017: -44.4%FY 2018: -39.0%FY 2019: -27.6%FY 2020: 40.8%FY 2021: 60.2%FY 2022: 0.4%FY 2023: 52.2%FY 2024: 36.6%FY 2025: 35.0%
FY 2016 FY 2025
Free Cash Flow -56.4%
FY 2016: -387.9%FY 2017: -121.8%FY 2018: -71.4%FY 2019: -24.5%FY 2020: 40.8%FY 2021: -37.5%FY 2022: -27.8%FY 2023: 5.2%FY 2024: -5.2%FY 2025: -56.4%
FY 2016 FY 2025

Financial Health

Current Ratio 6.1×
FY 2016: 5.8×FY 2017: 6.3×FY 2018: 10.3×FY 2019: 4.7×FY 2020: 6.5×FY 2021: 9.4×FY 2022: 9.8×FY 2023: 8.9×FY 2024: 5.2×FY 2025: 6.1×
FY 2016 5y median 8.9× FY 2025
Quick Ratio 6.1×
FY 2016: 5.8×FY 2017: 6.3×FY 2018: 10.3×FY 2019: 4.7×FY 2020: 6.5×FY 2021: 9.4×FY 2022: 9.8×FY 2023: 8.9×FY 2024: 5.2×FY 2025: 6.1×
FY 2016 5y median 8.9× FY 2025
Debt / Equity 0.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.2×FY 2024: 0.2×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 0.2×
FY 2016: 0.3×FY 2017: 1.0×FY 2018: 1.1×FY 2019: 0.6×FY 2020: 1.8×FY 2021: 1.7×FY 2022: 1.3×FY 2023: 0.5×FY 2024: 0.5×FY 2025: 0.2×
FY 2016 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: -382×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31